33.00
24-1月-25 16:45:00
15 分の遅延
株式
+0.30
+0.92%
本日の幅
31.74 - 33.37
ISIN
N/A
ソース
NASDAQ
Immunocore Announces Upcoming Presentations at the American Association for Cancer Research (AACR) 2021 Annual Meeting
10 3 2021 19:00:00 提供 Nasdaq GlobeNewswire
Immunocore’s tebentafusp granted Breakthrough Therapy Designation for unresectable or metastatic uveal melanoma from FDA
19 2 2021 07:00:00 提供 Nasdaq GlobeNewswire